Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Chem Inf Model ; 54(8): 2360-70, 2014 Aug 25.
Artigo em Inglês | MEDLINE | ID: mdl-25026200

RESUMO

Flavonoids, the vastest class of natural polyphenols, are extensively investigated for their multiple benefits on human health. Due to their physicochemical or biological properties, many representatives are considered to exhibit low selectivity among various protein targets or to plague high-throughput screening (HTS) outcomes. The aim of this study is to highlight reliable, bioselective compounds sharing flavonoidic scaffolds in HTS experiments. A filtering scheme was applied to remove undesired flavonoids (and related compounds) from confirmatory PubChem bioassays. A number of 433 compounds addressing various protein targets form the core of the collection of bioselective flavonoids and related compounds (ColBioS-FlavRC). With an additional set of 2908 inactive related compounds, ColBioS-FlavRC offers the grounds for method optimization and validation. We exemplified the use of ColBioS-FlavRC by pharmacophore modeling, subsequently (externally) validated for virtual screening purposes. The early enrichment capabilities of the pharmacophore hypotheses were measured by means of the median exponential retriever operating curve enrichment (MeROCE), a suited metric in comparative evaluations of virtual screening methods. ColBioS-FlavRC is available in the Supporting Information and is freely accessible for further studies.


Assuntos
Algoritmos , Flavonoides/química , Proteínas/química , Desenho de Fármacos , Ensaios de Triagem em Larga Escala , Humanos , Proteínas/agonistas , Proteínas/antagonistas & inibidores , Relação Quantitativa Estrutura-Atividade , Interface Usuário-Computador
2.
Bioorg Med Chem ; 21(5): 1268-78, 2013 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-23375446

RESUMO

In this study, a simple evaluation metric, denoted as eROCE was proposed to measure the early enrichment of predictive methods. We demonstrated the superior robustness of eROCE compared to other known metrics throughout several active to inactive ratios ranging from 1:10 to 1:1000. Group fusion similarity search was investigated by varying 16 similarity coefficients, five molecular representations (binary and non-binary) and two group fusion rules using two reference structure set sizes. We used a dataset of 3478 actives and 43,938 inactive molecules and the enrichment was analyzed by means of eROCE. This retrospective study provides optimal similarity search parameters in the case of ALDH1A1 inhibitors.


Assuntos
Algoritmos , Aldeído Desidrogenase/antagonistas & inibidores , Aldeído Desidrogenase/metabolismo , Família Aldeído Desidrogenase 1 , Biologia Computacional , Bases de Dados Factuais , Inibidores Enzimáticos/química , Humanos , Retinal Desidrogenase
3.
J Chem Inf Model ; 51(12): 3169-79, 2011 Dec 27.
Artigo em Inglês | MEDLINE | ID: mdl-22066983

RESUMO

Docking studies have become popular approaches in drug design, where the binding energy of the ligand in the active site of the protein is estimated by a scoring function. Many promising techniques were developed to enhance the performance of scoring functions including the fusion of multiple scoring functions outcomes into a so-called consensus scoring function. Hereby, we evaluated the target oriented consensus technique using the energetic terms of several scoring functions. The approach was denoted PLSDA-DOCET. Optimization strategies for consensus energetic terms and scoring functions based on ROC metric were compared to classical rigid docking and to ligand-based similarity search methods comprising 2D fingerprints and ROCS. The ROCS results indicate large performance variations depending on the biological target. The AUC-based strategy of PLSDA-DOCET outperformed the other docking approaches regarding simple retrieval and scaffold-hopping. The superior performance of PLSDA-DOCET protocol relative to single and combined scoring functions was validated on an external test set. We found a relative low mean correlation of the ranks of the chemotypes retrieved by the PLSDA-DOCET protocol and all the other methods employed here.


Assuntos
Algoritmos , Desenho de Fármacos , Proteínas/metabolismo , Domínio Catalítico , Ligantes , Ligação Proteica , Proteínas/química
4.
Bioorg Med Chem ; 14(22): 7490-500, 2006 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-16945540

RESUMO

A QSAR methodology that involves multilinear (Hansch-type) and nonlinear (ANN backpropagation) approaches was developed to correlate the antiplatelet activity of 60 benzoxazinone derivatives against factor Xa. The statistical characteristics provided by multilinear model (R2 = 0.821) indicated satisfactory stability and predictive ability, while the ANN predictive ability is somewhat superior (R2 = 0.909). The multilinear model provided insight into the main factors that modulate the inhibitory activity of the investigated compounds.


Assuntos
Plaquetas/efeitos dos fármacos , Inibidores da Agregação Plaquetária/química , Inibidores da Agregação Plaquetária/farmacologia , Relação Quantitativa Estrutura-Atividade , Algoritmos , Antitrombina III/química , Antitrombina III/farmacologia , Benzoxazinas/química , Benzoxazinas/farmacologia , Simulação por Computador , Fator Xa/metabolismo , Inibidores do Fator Xa , Modelos Químicos , Estrutura Molecular
5.
Bioorg Med Chem ; 14(14): 4987-5002, 2006 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-16650999

RESUMO

Quantitative structure-activity relationship (QSAR) models of the biological activity (pIC50) of 277 inhibitors of Glycogen Synthase Kinase-3 (GSK-3) are developed using geometrical, topological, quantum mechanical, and electronic descriptors calculated by CODESSA PRO. The linear (multilinear regression) and nonlinear (artificial neural network) models obtained link the structures to their reported activity pIC50. The results are discussed in the light of the main factors that influence the inhibitory activity of the GSK-3 enzyme.


Assuntos
Quinase 3 da Glicogênio Sintase/antagonistas & inibidores , Inibidores de Proteínas Quinases/química , Inibidores de Proteínas Quinases/farmacologia , Desenho de Fármacos , Humanos , Técnicas In Vitro , Modelos Lineares , Modelos Químicos , Redes Neurais de Computação , Dinâmica não Linear , Relação Quantitativa Estrutura-Atividade , Software
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...